Comment by mjamil

Given that it costs NN ~$5 to manufacture, and it's an effective drug that's an also-ran in the market, why still charge such a huge markup? NN should be selling it for $35-$50/month and buy the market share while feverishly working on a multi-GLP1 replacement.